Inogen, Inc. (INGN) Financials

INGN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 285.9 million 103.0 million
Dec. 31, 2025 298.6 million 106.4 million
Sept. 30, 2025 307.0 million 109.8 million
June 30, 2025 312.0 million 112.5 million

INGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -7.5 million ?
Dec. 31, 2025 -3.3 million 1.8 million
Sept. 30, 2025 64000 1.8 million
June 30, 2025 480000 2.3 million

INGN Net Income

No data available :(

INGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 111.5 million - 13.4 million
Dec. 31, 2025 119.6 million - 14.3 million
Sept. 30, 2025 124.5 million - 15.1 million
June 30, 2025 122.4 million - 19.0 million

INGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 27.3 million
Dec. 31, 2025 27.2 million
Sept. 30, 2025 26.4 million
June 30, 2025 27.0 million

INGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 781000 5.1 million 42.1 million 24.6 million
Dec. 31, 2025 2.4 million 5.3 million 39.2 million 23.1 million
Sept. 30, 2025 2.1 million 4.8 million 43.6 million 25.4 million
June 30, 2025 3.9 million 5.2 million 42.3 million 25.4 million

INGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 85.1 million 43.3 million
Dec. 31, 2025 81.7 million 40.5 million
Sept. 30, 2025 92.4 million 45.4 million
June 30, 2025 92.3 million 50.9 million

INGN

Price: $6.41

52 week price:
5.34
9.13

Earnings Per Share: -0.91 USD

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 86424

Ebitda: 11.8 million

Market Capitalization: 175.8 million

Links: